|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA03020019
|
20-trifluoro-LTB4
|
5S,12R-dihydroxy-20,20,20-trifluoro-6Z,8E,10E,14Z-eicosatetraenoic acid
|
|
C20H29O4F3
|
390.201796
|
|
LMFA03020019
|
20-trifluoro-LTB4
|
5S,12R-dihydroxy-20,20,20-trifluoro-6Z,8E,10E,14Z-eicosatetraenoic acid
|
|
C20H29O4F3
|
390.201796
|
|
LMFA08040069
|
N-(19,20-epoxy-4Z,7Z,13Z,16Z-docosapentaenoyl)-EA
|
N-(19(20)-epoxy-4Z,7Z,13Z,16Z-docosapentaenoyl)-ethanolamine
|
NAE 22:6;O
|
C24H37NO3
|
387.277344
|
|
LMFA08040069
|
N-(19,20-epoxy-4Z,7Z,13Z,16Z-docosapentaenoyl)-EA
|
N-(19(20)-epoxy-4Z,7Z,13Z,16Z-docosapentaenoyl)-ethanolamine
|
NAE 22:6;O
|
C24H37NO3
|
387.277344
|
|
LMFA08040069
|
N-(19,20-epoxy-4Z,7Z,13Z,16Z-docosapentaenoyl)-EA
|
N-(19(20)-epoxy-4Z,7Z,13Z,16Z-docosapentaenoyl)-ethanolamine
|
NAE 22:6;O
|
C24H37NO3
|
387.277344
|
|
LMFA08030049
|
N-(3-oxo-5Z-dodecenoyl)-homoserine lactone
|
N-(3-oxo-5Z-dodecenoyl)-homoserine lactone
|
|
C16H25NO4
|
295.178359
|
|
LMFA08030050
|
N-(5Z-dodecenoyl)-homoserine lactone
|
N-(5Z-dodecenoyl)-homoserine lactone
|
|
C16H27NO3
|
281.199094
|
|
LMFA03000025
|
|
12,17;13,17-Diepoxy-16-hydroxy-9Z-octadecenoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA08020311
|
N-benzyl-9-oxo-12Z-octadecenamide
|
N-9-oxo-12Z-octadecenoyl-benzylamine
|
NA 25:6;O
|
C25H39NO2
|
385.298079
|
|
LMFA08020307
|
N-(3,4-dimethoxybenzyl)-hexadecanamide
|
N-hexadecanoyl 3,4-dimethoxybenzylamine
|
NA 25:4;O2
|
C25H43NO3
|
405.324294
|
|
LMFA08020308
|
N-(3,4-dimethoxybenzyl)-9Z-oleamide
|
N-(9Z-octadecenoyl) 3,4-dimethoxybenzylamine
|
NA 27:5;O2
|
C27H45NO3
|
431.339944
|
|
LMFA08020309
|
N-benzyl-9-oxo-10E,12E-octadecadienamide
|
N-9-oxo-10E,12E-octadecadienoyl-benzylamine
|
NA 25:7;O
|
C25H37NO2
|
383.282429
|
|
LMFA08020312
|
N-benzyl-9-oxo-12Z,15Z-octadecadienamide
|
N-9-oxo-12Z,15Z-octadecadienoyl-benzylamine
|
NA 25:7;O
|
C25H37NO2
|
383.282429
|
|
LMFA03010061
|
11-deoxy-PGE2
|
9-oxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03120013
|
Bromovulone I
|
methyl 9-oxo-10-bromo-12R-hydroxy-5Z,7E,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
|
C21H29O4Br
|
424.124920
|
|
LMFA03120013
|
Bromovulone I
|
methyl 9-oxo-10-bromo-12R-hydroxy-5Z,7E,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
|
C21H29O4Br
|
424.124920
|
|
LMFA03120013
|
Bromovulone I
|
methyl 9-oxo-10-bromo-12R-hydroxy-5Z,7E,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
|
C21H29O4Br
|
424.124920
|
|
LMFA03120013
|
Bromovulone I
|
methyl 9-oxo-10-bromo-12R-hydroxy-5Z,7E,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
|
C21H29O4Br
|
424.124920
|
|
LMFA03120013
|
Bromovulone I
|
methyl 9-oxo-10-bromo-12R-hydroxy-5Z,7E,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
|
C21H29O4Br
|
424.124920
|
|
LMFA03120013
|
Bromovulone I
|
methyl 9-oxo-10-bromo-12R-hydroxy-5Z,7E,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
|
C21H29O4Br
|
424.124920
|
|
LMFA08020069
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
|
C27H46NOF
|
419.356343
|
|
LMFA08020069
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
|
C27H46NOF
|
419.356343
|
|
LMFA08020069
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
|
C27H46NOF
|
419.356343
|
|
LMFA08020069
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
(+/-)N-(2-fluoro-ethyl)-2,17,17-trimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
|
|
C27H46NOF
|
419.356343
|
|
LMFA08020056
|
N-(2-fluoro-ethyl) 2-methyl-arachidonoyl amine
|
N-(2-fluoro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine
|
|
C23H38NOF
|
363.293743
|
|
LMFA08020056
|
N-(2-fluoro-ethyl) 2-methyl-arachidonoyl amine
|
N-(2-fluoro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine
|
|
C23H38NOF
|
363.293743
|
|
LMFA08020056
|
N-(2-fluoro-ethyl) 2-methyl-arachidonoyl amine
|
N-(2-fluoro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine
|
|
C23H38NOF
|
363.293743
|
|
LMFA08020056
|
N-(2-fluoro-ethyl) 2-methyl-arachidonoyl amine
|
N-(2-fluoro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine
|
|
C23H38NOF
|
363.293743
|
|
LMFA03000027
|
TOG10
|
12-Oxo-10-(S-glutathionyl)-5Z,8Z,14Z-eicosatrienoic acid
|
|
C28H43N3O9S
|
597.272003
|
|
LMFA03000028
|
FOG7
|
5-oxo-7-(S-glutathionyl)-8Z,11Z,14Z-eicosatrienoic acid
|
|
C28H43N3O9S
|
597.272003
|
|
LMFA07040128
|
10S-methyl-6R-dodecanolide
|
10S-methyl-6R-dodecanolide
|
FA 13:1
|
C13H24O2
|
212.177630
|
|
LMFA01170150
|
13,14-dimethyloctacosanedioic acid
|
13,14-dimethyloctacosanedioic acid
|
FA 30:1;O2
|
C30H58O4
|
482.433511
|
|
LMFA01020436
|
sufac#1
|
13-methyl-10-(sulfooxy)tetradecanoic acid
|
|
C15H30O6S
|
338.176311
|
|
LMFA02010019
|
12-oxo-PDA-Ile
|
N-(1S,2S)-3-oxo-2-(2'Z-pentenyl)cyclopent-4-eneoctanyl isoleucine
|
|
C24H39NO4
|
405.287909
|
|
LMFA04030013
|
Resolvin D6i
|
4R,17R-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA13020006
|
16-(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)hexadecanoic acid 1',4''-lactone 6',6''-diacetate
|
16-{[6-O-acetyl-2-O-(6-O-acetyl-beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}hexadecanolide
|
|
C32H54O14
|
662.351361
|
|
LMFA10000009
|
11Z-etherolenic acid
|
12-[1'E,3'Z-hexadienyloxy]-9Z,11Z-dodecadienoic acid
|
FA 18:4;O
|
C18H28O3
|
292.203846
|
|
LMFA08020347
|
Thalassotalamide B
|
N-(8-methyl-nonanoyl)-2,3-(Z)-dehydrotyrosinamide
|
|
C19H28N2O3
|
332.209993
|
|
LMFA01030440
|
Nerolic acid
|
3,7-dimethyl-2Z,6-octadienoic acid
|
FA 10:2
|
C10H16O2
|
168.115030
|
|
LMFA01030440
|
Nerolic acid
|
3,7-dimethyl-2Z,6-octadienoic acid
|
FA 10:2
|
C10H16O2
|
168.115030
|
|
LMFA01170042
|
Equisetolic acid
|
Triacontanedioic acid
|
FA 30:1;O2
|
C30H58O4
|
482.433511
|
|
LMFA07040066
|
Parcoblattalactone
|
3Z,10Z-dodecadienoic acid 1,12-lactone
|
FA 12:3
|
C12H18O2
|
194.130680
|
|
LMFA07040066
|
Parcoblattalactone
|
3Z,10Z-dodecadienoic acid 1,12-lactone
|
FA 12:3
|
C12H18O2
|
194.130680
|
|
LMFA08020321
|
Tetrahydrobungeanool
|
N-(2-Hydroxy-2-methylpropyl)tetradeca-2E,4E-dienamide
|
NA 18:2;O
|
C18H33NO2
|
295.251129
|
|
LMFA13010033
|
Ustilagic acid
|
16-(O-(4'-O-(3'''-hydroxyhexanoyl)-beta-D-glucopyranosyl-(6'-O-acetyl)-beta-D-glucopyranosyl)-2,15,16-trihydroxy-hexadecanoic acid
|
|
C36H64O18
|
784.409271
|
|
LMFA08020322
|
|
2'-hydroxy-N-(isobutyl)-tetradeca-2E,4E,8Z-trienamide
|
NA 18:3;O
|
C18H31NO2
|
293.235479
|
|
LMFA13030021
|
Dokdolipid B
|
3-O-(alpha-L-rhamnopyranosyl)-3R-hydroxy-17-oxo-octadecanoic acid
|
|
C24H44O8
|
460.303621
|
|
LMFA02020211
|
N-jasmonoyl-L-dopa
|
N-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-Yl]cyclopentyl}acetyl)-L-dihydroxyphenylalanine
|
|
C21H27NO6
|
389.183839
|
|
LMFA02020212
|
N-jasmonoyl-dopamine
|
N-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-Yl]cyclopentyl}acetyl)-dopamine
|
|
C20H27NO4
|
345.194009
|
|
LMFA13030020
|
Dokdolipid A
|
3-O-(alpha-L-rhamnopyranosyl)-3R,17R-dihydroxy-octadecanoic acid
|
|
C24H46O8
|
462.319271
|